Paying users zone. Data is hidden behind: .
Get 1-month access to Abbott Laboratories for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Common-Size Income Statement
Abbott Laboratories, common-size consolidated income statement
Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17).
| Income statement item | Description | The company |
|---|---|---|
| Operating earnings | The net result for the period of deducting operating expenses from operating revenues. | Abbott Laboratories’s operating earnings as a percentage of net sales increased from 2018 to 2019 and from 2019 to 2020. |
| Earnings from continuing operations before taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Abbott Laboratories’s earnings from continuing operations before taxes as a percentage of net sales increased from 2018 to 2019 and from 2019 to 2020. |
| Net earnings | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Abbott Laboratories’s net earnings as a percentage of net sales increased from 2018 to 2019 and from 2019 to 2020. |